by GlobeNewsWire | Jul 6, 2016 | Globe Newswire
SOUTH SAN FRANCISCO, Calif., July 06, 2016 (GLOBE NEWSWIRE) — Achaogen, Inc. (NASDAQ:AKAO), a clinical-stage biopharmaceutical company developing novel antibacterials addressing multi-drug resistant (MDR) gram-negative infections, today announced that on July 5,...
by GlobeNewsWire | Jul 6, 2016 | Globe Newswire
SAN DIEGO, July 06, 2016 (GLOBE NEWSWIRE) — Apricus Biosciences, Inc. (Nasdaq:APRI) (the “Company” or “Apricus”), a biopharmaceutical company focusing on the development and commercialization of novel therapeutics to treat areas of unmet medical need, today...
by GlobeNewsWire | Jul 6, 2016 | Globe Newswire
NEW YORK and LONDON, July 06, 2016 (GLOBE NEWSWIRE) — Akari Therapeutics (NASDAQ:AKTX), an emerging growth, clinical-stage biopharmaceutical company, today announced positive interim data from the first cohort in its Phase Ib trial which demonstrates maintenance...
by GlobeNewsWire | Jul 5, 2016 | Globe Newswire
SOUTH SAN FRANCISCO, Calif., July 05, 2016 (GLOBE NEWSWIRE) — Cytokinetics, Inc. (Nasdaq:CYTK) announced today that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a corporate update at Cantor Fitzgerald’s 2nd Annual Healthcare...
by GlobeNewsWire | Jul 5, 2016 | Globe Newswire
BURLINGTON, Mass., July 05, 2016 (GLOBE NEWSWIRE) — ArQule, Inc. (Nasdaq:ARQL) today announced that Paolo Pucci, Chief Executive Officer, and Dr. Brian Schwartz, Chief Medical Officer and Head of Research and Development, will present at Cantor Fitzgerald’s 2nd...